Enhancing the Efficiency of the Individual Case Safety Report (ICSR) Quality and Compliance through Automation

Author:

Link Shannon1,Kammler Adam1,Gupta Ritu2,Hembade Mahendra3,Kumar Retesh4,George Vinu5

Affiliation:

1. Global Pharmacovigilance Compliance and Business Management (Compliance & Analytics), Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, New Jersey, 08540, USA

2. Product Strategy, Vitrana Inc., Cranbury, New Jersey, 08512, USA

3. Global Pharmacovigilance Compliance and Business Management (Compliance & Analytics), Tata Consultancy Services, Thane, Maharashtra, 400607, India

4. Global Pharmacovigilance Medical Safety, Otsuka Pharmaceutical Europe Limited (OPEL). Gallions Wexham Springs, Framewood Rd, Wexham, SL3 6PJ, United Kingdom

5. Global Pharmacovigilance, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, New Jersey, 08540, USA

Abstract

Background: Over the past few years, major inspection findings have been identified in the “management of adverse reactions” that may be due to increasing workload in pharmaceutical organizations impacting the correctness of information in individual case safety reports (ICSRs). Although retrospective quality check (Retro-QC) and late submission analyses are important steps in ensuring ICSR quality, their manual application poses several challenges that can be overcome through automation. Objective: To improve the efficiency of the Retro-QC analysis and late submission analysis using a computer-operated tool called Compliance and Metrics Management (CMM) tool, and to measure the tool’s effectiveness in terms of productivity, time, and cost savings by comparing against the manual process. Methods: Time savings were calculated by measuring the difference in time taken during the manual process versus the automated process. Cost savings were measured in terms of hourly remuneration for the time saved. Productivity was calculated as the difference between the number of cases handled in the manual versus automated process. Thus, the overall efficiency was measured in terms of time and cost savings along with increased productivity. Results: Automation resulted in time savings of 49% and cost savings of 43% for Retro-QC analysis, and the productivity level increased by 67%. For late submission analysis, the CMM tool resulted in time savings of 88% and cost savings of 87%. Conclusion: CMM tool enhanced the efficiency of both Retro-QC and late submission analyses by increasing productivity along with time and cost savings. It also reduced the number of errors, thereby enhancing the accuracy of the process and overall compliance.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference16 articles.

1. Individual case safety reports and vigibase – the vital importance of quality Available from:[Accessed on: Dec 29, 2022]2022

2. Guideline on good pharmacovigilance practices (GVP), 2012: Module I – Pharmacovigilance systems and their quality systems. Available from: [Accessed on: Dec 29, 2022]2012

3. Medicines and Healthcare products regulatory agency. Pharmacovigilance Inspection Metrics Report April 2018 – March 2019. Available from: [Accessed on: Mar 31, 2023]2018

4. Medicines and Healthcare products regulatory agency. Pharmacovigilance Inspection Metrics Report April 2019 – March 2020. Available from: [Accessed on: Mar 31, 2023]2019

5. Medicines and Healthcare products regulatory agency. Pharmacovigilance Inspection Metrics Report April 2020 – March 2021. Available from: [Accessed on: Mar 31, 2023]2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3